CA - Crescita Therapeutics GAAP EPS of C$0.01 revenue of C$6.03M November, 09 2022 08:53 AM CA Inc. Crescita Therapeutics press release ( OTCPK:CRRTF ): Q3 GAAP EPS of C$0.01. Revenue of C$6.03M (+101.7% Y/Y). For further details see: Crescita Therapeutics GAAP EPS of C$0.01, revenue of C$6.03M